We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Recommendations on Postmarket Studies for Devices
FDA Issues Recommendations on Postmarket Studies for Devices
The FDA details its expectations for postmarket surveillance of moderate and high-risk devices in two draft guidances, including its criteria for ordering postmarket data collection.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor